Brief report: meningitis due to iatrogenic BCG infection in two immunocompromised children.
Stone
M M
MM
Department of Pediatric, Kaiser Permanente Medical Center, Woodland Hills, Calif., USA.
Vannier
A M
AM
Storch
S K
SK
Peterson
C
C
Nitta
A T
AT
Zhang
Y
Y
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D002675:Child, Preschool; D004340:Drug Contamination; D005000:Ethionamide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007049:Iatrogenic Disease; D016867:Immunocompromised Host; D007538:Isoniazid / Q000008:administration & dosage; D008297:Male; D016920:Meningitis, Bacterial / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000382:microbiology*; D009163:Mycobacterium bovis / Q000302:isolation & purification*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D011718:Pyrazinamide / Q000008:administration & dosage; D012293:Rifampin / Q000008:administration & dosage; D013307:Streptomycin / Q000008:administration & dosage; D014390:Tuberculosis, Meningeal / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000382:microbiology*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin